First Potent Macrocyclic A3 Adenosine Receptor Agonists Reveal G-Protein and β-Arrestin2 Signaling Preferences is a research paper published in ACS Pharmacology & Translational Science (2023). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: ZIADK031117
National Heart, Lung, and Blood Institute
Grant: HL133589
NHLBI NIH HHS
Grant: R01 HL133589
NHLBI NIH HHS
Grant: F31 HL160193
National Institutes of Health
Grant: 5R01HL133589-02
Adenosine Signaling During Post-Infarction Remodeling and Heart Failure
National Institutes of Health
Grant: 1ZIADK031117-26
Development Of Drugs Acting At Adenosine Receptors
FWCI
0.37
Citation Percentile
0.5%
Citation Trend
Fields of Study
Keywords